Many individuals visit emergency rooms for severe hypoglycaemia, of which some will be hospitalized due to this safety concern. In this touchENDOCRINOLOGY interview, we speak with Dr Diana Isaacs (Endocrine Clinical Pharmacy Specialist, Cleveland Clinic, Cleveland, OH, USA) to discuss the classification and treatment options for hypoglycaemia, and clinical experience and evidence-based practices for the treatment and prevention of hypoglycaemia.
The abstract entitled: ‘Don’t Go Low! Clinical Strategies on Optimal Treatment and Prevention of Hypoglycemia‘ was presented at the Association of Diabetes Care & Education Specialists (ADCES) Annual Conference, 12-15 Aug, 2022
Questions:
- Could you give us an overview of the health burden of hypoglycaemia in diabetes? (0:15)
- How is hypoglycaemia classified? (0:42)
- What are the treatment options for hypoglycaemia? (1:17)
- Why is glucagon underutilized in cases of hyperglycaemia? (2:14)
- What changes are needed in routine clinical practice in the prevention and treatment of hypoglycaemia? (3:46)
Disclosures: Diana Isaacs is a consultant for Eli Lilly, and Sanofi; and is a speaker’s bureau participant for Dexcom, Abbott, Bayer, Insulet, Medtronic, Cequr, and Novo Nordisk.
Support: Interview supported by Touch Medical Media. Interview conducted by Katey Gabrysch.
Recorded as a highlight of ADCES 2022
Click here for more related content.
